Valuation (12%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -4.20 | -18.94 |
PEG Ratio (TTM) | -0.06 | -5.61 |
P/S Ratio (TTM) | 100.24 | 47.90 |
P/B Ratio (TTM) | 2.25 | 30.89 |
P/FCF Ratio (TTM) | -1.64 | -6.05 |
Price to 5YR AVG Earnings Ratio | -0.05 | -5.69 |
Price to 5YR AVG FCF Ratio | -0.79 | -13.62 |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -44.60% | -17.89% |
ROE (TTM) | -43.77% | 28.85% |
Net Profit Margin (TTM) | -6,892.70% | -540.96% |
ROIC 5YR AVG | -271.94% | -3.04% |
Growth (50%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | 9.14% | 33.18% | 46.40% |
Revenue | 14.69% | 1,504.43% | 881.08% |
Net Income | -18.69% | -76.12% | -31.69% |
Cash Flow | -15.42% | -25.05% | -2.75% |
Health (32%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 5.81 | 5.75 |
Quick Ratio (TTM) | 5.81 | 5.53 |
D/E Ratio (TTM) | N/A | 1.08 |
Interest Coverage (TTM) | -143.34 | -7.40 |
Piotroski F-Score | 2 | 5 |
Altman Z-Score | N/A | 13.03 |
LTL to 5YR AVG FCF | 0.00 | 0.08 |
Shares Outstanding Growth 5YR AVG | 126.26% | 40.65% |